GTCbio’s 8th Annual Vaccines: All Things Considered Conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development including research, manufacturing, regulations, investment, and policy in a comfortable, interactive and friendly setting. The 8th Vaccines: All Things Considered Conference brings together the top names in vaccinology from industry leaders like Merck, Novartis and many more, as well as from academia and the government for practical discussions of the future of our discipline. Don’t miss this opportunity to take all things into consideration. We look forward to welcoming you into our discussions of all things vaccines!